News & Updates

Which factors predict sustained RA remission with MTX or ETN monotherapy?
Which factors predict sustained RA remission with MTX or ETN monotherapy?
12 Sep 2023 byStephen Padilla

Following the switch from combination therapy to monotherapy, rheumatoid arthritis (RA) patients with overall lower disease activity (LDA) have higher odds of achieving and remaining in Simplified Disease Activity Index (SDAI) remission/LDA, suggests a study.

Which factors predict sustained RA remission with MTX or ETN monotherapy?
12 Sep 2023
Glucocorticoid discontinuation may prevent infection in older RA patients
Glucocorticoid discontinuation may prevent infection in older RA patients
05 Aug 2023

For older patients with rheumatoid arthritis (RA) who are receiving glucocorticoids (GCs), stopping its use lowers the incidence of infection, according to a study.

Glucocorticoid discontinuation may prevent infection in older RA patients
05 Aug 2023
RA remission rates higher with abatacept, certolizumab pegol vs conventional therapy
RA remission rates higher with abatacept, certolizumab pegol vs conventional therapy
17 Jul 2023

In the treatment of rheumatoid arthritis (RA), more patients achieve clinical remission with abatacept or certolizumab pegol, but not with tocilizumab, than with active conventional therapy, according to a study.

RA remission rates higher with abatacept, certolizumab pegol vs conventional therapy
17 Jul 2023
Anxiety, depression jeopardize health of axSpA patients
Anxiety, depression jeopardize health of axSpA patients
14 Jul 2023 byJairia Dela Cruz

Patients with axial spondyloarthritis (axSpA) may experience a decline in their overall health and functioning due to the presence of comorbid anxiety and depression, as reported in a study from Singapore.

Anxiety, depression jeopardize health of axSpA patients
14 Jul 2023